The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Purdue Pharma has filed a patent-infringement suit against Ranbaxy, Actavis Elizabeth and Mylan Pharmaceuticals after the companies submitted applications to market a generic version of the painkiller OxyContin. The three generic-drug makers’ ANDAs to market generic OxyContin (oxycodone HCl) would infringe Purdue’s ’799, ’800 and ’072 patents on the drug, Purdue says in its complaint filed in the U.S. District Court for the Southern District of New York. Generic Line